- The total securities market turnover on the Singapore Exchange (SGX) for January was S$20.84 billion.
- The derivatives market saw a volume of 23.90 million contracts during the same period.
- The daily average volume for derivatives trading was recorded at 1.24 million contracts.
- Among the analyst recommendations, there were 7 buy ratings, 5 hold ratings, and 3 sell ratings.
A look at SGX Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Singapore Exchange Limited (SGX) shows a promising long-term outlook. With solid scores in Growth, Resilience, and Momentum, SGX appears to be in a favorable position for sustained performance. The company’s strong Growth and Resilience scores suggest potential for future expansion and stability, while its high Momentum score indicates a positive trend in stock performance. Although SGX‘s scores for Value and Dividend are moderate, the overall outlook appears optimistic, pointing towards potential growth and resilience in the long term.
Singapore Exchange Limited, the owner and operator of Singapore’s securities and derivatives exchange, along with related clearing houses, also offers essential securities processing and IT services to financial industry participants. With a strong focus on growth, resilience, and momentum, SGX‘s Smartkarma Smart Scores indicate a positive trajectory for the company’s future performance, despite moderate ratings in value and dividend. Investors may view SGX as a promising prospect for long-term investment based on these scores and the company’s core operations in Singapore’s financial markets.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
